Onyx Frontier™ ONYXNG40008UXRecalls & reported problems
Medtronic, Inc. · STENT ONYXNG40008UX ONYX 4.00X08RX · Class 3 · Implant
All models of Onyx Frontier (71)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00763000511630), received between Jun 13, 2023 and Aug 18, 2025 — classified as 1 death, 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Device Damaged by Another Device” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Damaged by Another Device2
- Device Dislodged or Dislocated2
- Material Deformation2
- Defective Component1
- Detachment of Device or Device Component1
- Positioning Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Device Embedded In Tissue or Plaque1
- Gastrointestinal Hemorrhage1
- Insufficient Information1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 18, 2025Device Damaged by Another Device; Device Dislodged or Dislocated; Material Deformation; Positioning Problem; Device Damaged by Another Device; Device Dislodged or Dislocated; Material Deformation; Positioning Problem
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING ONE ONYX FRONTIER CORONARY DRUG-ELUTING STENT, STENT DISLODGEMENT OCCURRED DURING DELIVERY TO/AT THE LESION. THE LESION BEING TREATED WAS NON TORTUOUS, NON CALCIFIED, WITH 80% STENOSIS IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY. IT WAS STATED THAT THE LESION WAS A BIFURCATION LESION. THE DIAGONAL ARTERY WAS STENTED FIRST, WHICH JUTTED INTO THE LAD. PLAQUE WAS SNOW PLOWED INTO THE LAD WHICH REQUIRED THE LAD TO BE STENTED. THE DEVICE WAS INSPECTED PRIOR TO USE AND NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE LESION WAS PRE-DILATED. THE DEVICE PASSED THROUGH A PREVIOUSLY-DEPLOYED STENT. RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. THE STENT WAS ORIGINALLY ATTEMPTED TO BE DELIVERED BUT THE STENT FROM THE DIAGONAL WAS IMPEDING DELIVERY. THE SYSTEM WAS SUCCESSFULLY REMOVED AND THE LESION AND DIAGONAL STENT WAS PREDILATED WITH A 3.0 X 12MM EUPHORA BALLOON. THEN THE STENT WAS ATTEMPTED TO BE DELIVERED AGAIN. A 7F LAUNCHER GUIDE CATHETER, TWO NON-MEDTRONIC WIRES AND THE 3.0 X 12MM EUPHORA WERE BEING USED IN THE DIAGONAL. THE KISSING STENT AND BALLOON TECHNIQUE WAS INTENDED
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22825251 ↗DeathJul 30, 2025Device Damaged by Another Device; Material Deformation; Device Damaged by Another Device; Material Deformation
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING ONE ONYX FRONTIER CORONARY DRUG-ELUTING STENT, THE STENT WAS DAMAGED BY ANOTHER DEVICE. THE LESION BEING TREATED WAS MODERATELY TORTUOUS AND MODERATELY CALCIFIED LOCATED IN THE OSTIUM OF THE LEFT MAIN (LM) CORONARY ARTERY. THE STENT WAS PLACED AND SUCCESSFULLY DEPLOYED IN THE LM. ANOTHER STENT WAS THEN PLACED IN THE LEFT ANTERIOR DESCENDING A RTERY(LAD). ANOTHER STENT WAS PLACED IN THE RAMUS USING A NON-MEDTRONIC GUIDEWIRE. WHEN IT WAS ATTEMPTED TO RETRIEVE THE GUIDEWIRE, IT LOCKED UP WITH THE DEPLOYED STENT IN THE LM. THE GUIDEWIRE WAS PULLED AND THE STENT WAS EXPANDED AND REMOVED FROM THE PATIENT STUCK TO THE GUIDEWIRE. THE STENT DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE AND NO EXCESSIVE FORCE WAS USED DURING DELIVERY. THE STENT WAS INSPECTED PRIOR TO USE AND NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE PATIENT DIED THE FOLLOWING DAY. THE PHYSICIAN ASSESSED THAT THE DEATH WAS RELATED TO GASTROINTESTINAL (GI) BLEED AND WAS NOT DUE TO THE ISSUES ENCOUNTERED WITH THE STENT.
Patient problems: Gastrointestinal Hemorrhage
MAUDE report 22662798 ↗InjuryMar 12, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT DURING A CARDIAC CATHETERIZATION PROCEDURE, AN ONYX FRONTIER CORONARY DRUG ELUTING STENT BECAME DISLODGED FROM THE DELIVERY DEVICE AND TRAVELED TO THE LEFT PERONEAL ARTERY WHERE IT WAS THEN INFLATED. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: Device Embedded In Tissue or Plaque; Insufficient Information
MAUDE report 21582964 ↗MalfunctionOct 16, 2024Detachment of Device or Device Component; Detachment of Device or Device Component
AN ATTEMPT WAS MADE TO USE ONE ONYX FRONTIER CORONARY DRUG ELUTING STENT TO TREAT A LESION. THE STENT WAS DEPLOYED SUCCESSFULLY. IT WAS REPORTED THAT THE STENT DEPLOYMENT BALLOON SYSTEM CAME APART WHILE BEING REMOVED AFTER DEPLOYING THE STENT. THE DELIVERY SYSTEM WAS INSIDE THE GUIDE CATHETER AT THE TIME. THE GUIDE WAS SUCCESSFULLY REMOVED WITH THE STENT SYSTEM INSIDE. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20461968 ↗MalfunctionJun 13, 2023Defective Component; Defective Component
AN ATTEMPT WAS MADE TO USE ONE 4.0X8MM ONYX FRONTIER CORONARY DRUG ELUTING STENT (DES) TO TREAT A LESION IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS NOT PERFORMED. IT WAS REPORTED THAT THE STENT APPEARED TO BE LONGER THAN 8MM. A 12MM LENGTH NON-MEDTRONIC BALLOON WAS USED AND IT WAS NOTED TO BE THE SAME SIZE AS THE STENT. THE ONYX FRONTIER STENT WAS IMPLANTED WITH NO ISSUES DESPITE THAT IT MAY HAVE BEEN LONGER THAN 8MM. THE PATIENT IS ALIVE WITH NO INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17121357 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page